原著 |
|
|
|
|
大剂量维生素C通过减少糖酵解和蛋白质合成抑制乳腺癌细胞增殖 |
王青梅( ),徐千姿,魏安怡,陈世硕,张翀*( ),曾玲晖*( ) |
浙江大学城市学院医学院, 浙江 杭州 310015 |
|
High dose vitamin C inhibits proliferation of breast cancer cells through reducing glycolysis and protein synthesis |
WANG Qingmei( ),XU Qianzi,WEI Anyi,CHEN Shishuo,ZHANG Chong*( ),ZENG Linghui*( ) |
School of Medicine, Zhejiang University City College, Hangzhou 310015, China |
引用本文:
王青梅, 徐千姿, 魏安怡, 陈世硕, 张翀, 曾玲晖. 大剂量维生素C通过减少糖酵解和蛋白质合成抑制乳腺癌细胞增殖[J]. 浙江大学学报(医学版), 2019, 48(3): 296-302.
WANG Qingmei, XU Qianzi, WEI Anyi, CHEN Shishuo, ZHANG Chong, ZENG Linghui. High dose vitamin C inhibits proliferation of breast cancer cells through reducing glycolysis and protein synthesis. J Zhejiang Univ (Med Sci), 2019, 48(3): 296-302.
链接本文:
http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2019.06.10
或
http://www.zjujournals.com/med/CN/Y2019/V48/I3/296
|
1 |
CHEN W , ZHENG R , BAADE P D et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66 (2): 115- 132
doi: 10.3322/caac.21338
|
2 |
BRAY F , JEMAL A , GREY N et al. Global cancer transitions according to the Human Development Index(2008-2030):a population-based study[J]. Lancet Oncol, 2012, 13 (8): 790- 801
doi: 10.1016/S1470-2045(12)70211-5
|
3 |
HAO C , WANG Z , GU Y et al. Prognostic value of osteopontin splice variant-c expression in breast cancers:a meta-analysis[J]. Biomed Res Int, 2016, 2016:7310694
|
4 |
MARTINI E . Jacques Cartier witnesses a treatment for scurvy[J]. Vesalius, 2002, 8 (1): 2- 6
|
5 |
MIKIROVA N , CASCIARI J , ROGERS A et al. Effect of high-dose intravenous vitamin C on inflammation in cancer patients[J]. J Transl Med, 2012, 10:189
doi: 10.1186/1479-5876-10-189
|
6 |
HANAHAN D , WEINBERG R A . Hallmarks of cancer:the next generation[J]. Cell, 2011, 144 (5): 646- 674
doi: 10.1016/j.cell.2011.02.013
|
7 |
WARBURG O . On the origin of cancer cells[J]. Science, 1956, 123 (3191): 309- 314
doi: 10.1126/science.123.3191.309
|
8 |
NGO D C , VERVERIS K , TORTORELLA S M et al. Introduction to the molecular basis of cancer metabolism and the Warburg effect[J]. Mol Biol Rep, 2015, 42 (4): 819- 823
doi: 10.1007/s11033-015-3857-y
|
9 |
VOLLBRACHT C , SCHNEIDER B , LEENDERT V et al. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare:results of a retrospective, multicentre, epidemiological cohort study in Germany[J]. In Vivo, 2011, 25 (6): 983- 990
|
10 |
CONCIATORI F, CIUFFREDA L, BAZZICHETTO C, et al. mTOR cross-talk in cancer and potential for combination therapy[J/OL]. Cancers(Basel), 2018, 10(1). pii: E23.
|
11 |
WULLSCHLEGER S , LOEWITH R , HALL M N . TOR signaling in growth and metabolism[J]. Cell, 2006, 124 (3): 471- 484
doi: 10.1016/j.cell.2006.01.016
|
12 |
DAZERT E , HALL M N . mTOR signaling in disease[J]. Curr Opin Cell Biol, 2011, 23 (6): 744- 755
doi: 10.1016/j.ceb.2011.09.003
|
13 |
HAY N , SONENBERG N . Upstream and downstream of mTOR[J]. Genes Dev, 2004, 18 (16): 1926- 1945
doi: 10.1101/gad.1212704
|
14 |
YUN J , MULLARKY E , LU C et al. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH[J]. Science, 2015, 350 (6266): 1391- 1396
doi: 10.1126/science.aaa5004
|
15 |
MA Y , CHAPMAN J , LEVINE M et al. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy[J]. Sci Transl Med, 2014, 6 (222): 222ra18
doi: 10.1126/scitranslmed.3007154
|
16 |
MONTI D A, MITCHELL E, BAZZAN A J, et al. Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer[J/OL]. PLoS One, 2012, 7(1): e29794.
|
17 |
YEOM C H , JUNG G C , SONG K J . Changes of terminal cancer patients' health-related quality of life after high dose vitamin C administration[J]. J Korean Med Sci, 2007, 22 (1): 7- 11
doi: 10.3346/jkms.2007.22.1.7
|
18 |
CAMERON E , CAMPBELL A , JACK T . The orthomolecular treatment of cancer. Ⅲ. Reticulum cell sarcoma:double complete regression induced by high-dose ascorbic acid therapy[J]. Chem Biol Interact, 1975, 11 (5): 387- 393
doi: 10.1016/0009-2797(75)90007-1
|
19 |
CAMERON E , PAULING L . Supplemental ascorbate in the supportive treatment of cancer:reevaluation of prolongation of survival times in terminal human cancer[J]. Proc Natl Acad Sci U S A, 1978, 75 (9): 4538- 4542
doi: 10.1073/pnas.75.9.4538
|
20 |
MOERTEL C G , FLEMING T R , CREAGAN E T et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison[J]. N Engl J Med, 1985, 321 (3): 137- 141
|
21 |
CREAGAN E T , MOERTEL C G , O'FALLON J R et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial[J]. N Engl J Med, 1979, 301 (13): 687- 690
doi: 10.1056/NEJM197909273011303
|
22 |
SAXTON R A , SABATINI D M . mTOR signaling in growth, metabolism, and disease[J]. Cell, 2017, 169 (2): 361- 371
|
23 |
LI H , LIU X , WANG Z et al. MEN1/Menin regulates milk protein synthesis through mTOR signaling in mammary epithelial cells[J]. Sci Rep, 2017, 7 (1): 5479
doi: 10.1038/s41598-017-06054-w
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|